Showing 120 of 120on this page. Filters & sort apply to loaded results; URL updates for sharing.120 of 120 on this page
Charles River announces Bit Bio partnership, increasing drug discovery ...
Introducing Bit Bio — coding cells, the building blocks of life.
bit.bio Secures $50M in Funding for Human Cell Programming Tech | bit ...
Bit Bio: Cell Coding for Drug discovery and Cell Therapy – Digital ...
Synthetic biology for human health | bit.bio
BlueRock Therapeutics and bit.bio announce collaboration and option ...
bit.bio Launches ioTracker Cells Range at SLAS 2025, Adding New ...
May 24 2023
bit.bio chooses Automata for automating an aspect of its production of ...
Synthetic Biology for Human Health | Cells Reprogrammed | bit.bio
bit.bio Wins Landmark Patent Defence for Groundbreaking opti-ox™ Cell ...
bit.bio launches first-of-their-kind human iPSC-derived cells for gene ...
Bit.bio Raises $50 M Series C Round To Scale Human Cell Programming ...
This Startup Is Making — and Programming — Human Cells
bit.bio Unveils Cell Therapy Pipeline, Including Lead Candidate for ...
bit.bio elevated to UK tech elite
bit.bio launches new custom disease model cells offering, advancing ...
bit.bio joins ‘Future Fifty’ as one of UK’s exciting tech companies
bit.bio accelerates global access to human cells with new pricing model ...
bit.bio | Make every well in every assay count with our disease models
bit.bio is industrialising human cell manufacturing
bit.bio secures $50 million Series C to scale human cell programming ...
About us | bit.bio
RNA-sequencing workshop Top tips for human iPSC-derived cells | bit.bio
IoPPN scientists collaborate with bit.bio to develop multi-cell models ...
bit.bio featured in HealthTechWorld
bit.bio's Latest Innovation, ioCRISPR-Ready Cells, Streamlines Human ...
Consistent, Scalable Human Cells for Cell Therapies | bit.bio
The next disruptive technology in medicine: human biology | bit.bio
Our platform for Reprogramming Cell Identity | Technology | bit.bio
Cell counting workshop | Top tips for human iPSC-derived cells | bit.bio
bit.bio to Unveil iPSC Advancements and ioCells Toolkit at Society for ...
Series C $50m boosts bit.bio in new era of cell test opportunities
UK Science Minister Andrew Griffith MP opens bit.bio expanded labs
About bit.bio
bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells ...
Time to shine: bit.bio sets a high bar for Life Sciences
Synthetic Biology for Human Health | Cells Reprogrammed | bit.bio | bit.bio
Welcome to bit.bio -"Transforming Medicine: Synthetic Biology for Drug ...
bit.bio | featured on built with biology podcast
La biotecnológica británica Bit.bio recorta su plantilla en un 25% y ...
Sensory Neurons | ioCells
bit.bio Adds Two New Human Cell Products To Accelerate Research and ...
bit.bio launches Early Access programme for ioHepatocytes, a new iPSC ...
bit.bio | Technology Networks
Custom disease model cells | bit.bio
bit.bio + London Institute for Mathematical Sciences = progress on ...
Bit.Bio and BlueRock Set to Revolutionize Cell Therapy with New ...
bit.bio discovery | Our factsheet
Protocol library | ioCells | bit.bio
bit.bio | team expands to further prepare for cell therapies
BIT.BIO.BOT: a prototype dwelling and collective experiment in biotech ...
Progress in applying human iPSC-derived cells to drug discovery | bit.bio
bit.bio launches ioAstrocytes
bit.bio launches ioAstrocytes - Brands Review Magazine
Bit.bio secures $50 million Series C to scale human cell programming ...
Our platform and opti-ox™ - cell programming technology | bit.bio
Consistent and Scalable iPSC-Derived Cells | ioCells | bit.bio
bit.bio cell revolution looks to transform dementia treatments and grow ...
Reprogramming stem cells: a new innovative technology for the ...
Science minister opens bi.bio’s new labs as sector gets £2bn ‘Vision’ boost
bit.bio | ioDisease Model Cell Panels | bit.bio
bit.bio Expands Its Portfolio With Three New Human Cell Products for ...
bit.bio Launches New Custom Disease Model Cells Offering, Advancing ...
ioSkeletal Myocytes | ioCells | bit.bio
bit.bio launches custom disease model cells - Drug Discovery World (DDW)
Synthetic biology for human health | bit.bio | bit.bio
bit.bio a synthetic biology company that was spun out of Cambridge ...
bit.bio discovery is hiring. Appy now! | biotechjobs.at
Reprogramming Human Cells With bit.bio's Mark Kotter, M.D. - YouTube
Cytogenetic QC at bit.bio: How a next-generation cytogenetics platform ...
bit.bio unveils cell therapy pipeline, lead candidate and expanded SAB
bit.bio Unveils Ambitious 2025 Sustainability Report with Key ...
bit.bio announces collaboration with The Michael J. Fox Foundation ...
bit.bio | Academic hub
Team:BIT/Bio/Overview - 2018.igem.org
bit.bio on LinkedIn: The power of automation featured in Scientist Live
Order help request | bit.bio
Bit.Bio.Bot | photoSynthetica
How bit.bio uses opti-ox™ to create human cells | bit.bio posted on the ...
Audacious bit.bio nets $103m for first close of Series B round
bit.bio introduces ioTracker cells - Clinical Laboratory int.
Explore open roles | Working at bit.bio | bit.bio
bit.bio clears the way for next phase of growth
BIT.BIO.BOT | ecoLogicStudio
bit.bio pipeline starts delivering clinical-trial candidates as SAB expands
bit.bio unveils first Parkinson’s project with The Michael J. Fox ...
bit.bio HubSpot eCommerce Implementation | Blend
txTreg Cells(Bit Bio) - Drug Targets, Indications, Patents - Synapse
Open Roles | Job Applications | bit.bio
Jobs at bit.bio
bit.bio Adds Two New Human Cell Products to Address the Translation Gap ...
bit.bio launches 16 disease models for neurodegenerative disease
.png?width=906&name=Lab%20automation%20PS%20(1).png)
%20(1).png)
.jpg)
.png)
